T Lymphoblastic Leukemia/Lymphoma — Trials

T Lymphoblastic Leukemia/Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

140 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 57
Recruiting: 35
Ph III recruiting: 2
Growth YoY: —
Industry share: 12%
Top sponsor: Institute of Hematology & Blood Diseases Hospital, China
Termination share: 48.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (24)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02652715	Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma	completed	N/A	29	Mayo ClinicOTHER	1	Nov 15, 2019	clinicaltrials
NCT00049569	Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia	completed	N/A	126	National Cancer Institute (NCI)NIH	1	Oct 8, 2013	clinicaltrials